235 related articles for article (PubMed ID: 9379000)
1. Dual role of IL-12 in early and late stages of murine collagen type II arthritis.
Joosten LA; Lubberts E; Helsen MM; van den Berg WB
J Immunol; 1997 Oct; 159(8):4094-102. PubMed ID: 9379000
[TBL] [Abstract][Full Text] [Related]
2. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
3. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
[TBL] [Abstract][Full Text] [Related]
4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein.
Mindrescu C; Thorbecke GJ; Klein MJ; Vilcek J; Wisniewski HG
Arthritis Rheum; 2000 Dec; 43(12):2668-77. PubMed ID: 11145024
[TBL] [Abstract][Full Text] [Related]
6. Important role of interleukin-3 in the early phase of collagen-induced arthritis.
Brühl H; Cihak J; Niedermeier M; Denzel A; Rodriguez Gomez M; Talke Y; Goebel N; Plachý J; Stangassinger M; Mack M
Arthritis Rheum; 2009 May; 60(5):1352-61. PubMed ID: 19404955
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis.
Saidenberg-Kermanac'h N; Bessis N; Deleuze V; Bloquel C; Bureau M; Scherman D; Boissier MC
J Gene Med; 2003 Feb; 5(2):164-71. PubMed ID: 12539154
[TBL] [Abstract][Full Text] [Related]
8. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
9. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of electroacupuncture on murine collagen arthritis and its possible mechanisms.
Fang JQ; Aoki E; Yu Y; Sohma T; Kasahara T; Hisamitsu T
In Vivo; 1999; 13(4):311-8. PubMed ID: 10586371
[TBL] [Abstract][Full Text] [Related]
11. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis.
Härle P; Möbius D; Carr DJ; Schölmerich J; Straub RH
Arthritis Rheum; 2005 Apr; 52(4):1305-13. PubMed ID: 15818682
[TBL] [Abstract][Full Text] [Related]
12. Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis.
Parks E; Strieter RM; Lukacs NW; Gauldie J; Hitt M; Graham FL; Kunkel SL
J Immunol; 1998 May; 160(9):4615-9. PubMed ID: 9574569
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of lipopolysaccharide exacerbates collagen-induced arthritis in mice.
Yoshino S; Sasatomi E; Mori Y; Sagai M
J Immunol; 1999 Sep; 163(6):3417-22. PubMed ID: 10477613
[TBL] [Abstract][Full Text] [Related]
15. Biphasic regulation of the development of murine type II collagen-induced arthritis by interleukin-12: possible involvement of endogenous interleukin-10 and tumor necrosis factor alpha.
Kasama T; Yamazaki J; Hanaoka R; Miwa Y; Hatano Y; Kobayashi K; Negishi M; Ide H; Adachi M
Arthritis Rheum; 1999 Jan; 42(1):100-9. PubMed ID: 9920020
[TBL] [Abstract][Full Text] [Related]
16. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice.
Hansson M; Djerbi M; Rabbani H; Mellstedt H; Gharibdoost F; Hassan M; Depierre JW; Abedi-Valugerdi M
Immunology; 2005 Mar; 114(3):428-37. PubMed ID: 15720444
[TBL] [Abstract][Full Text] [Related]
17. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
[TBL] [Abstract][Full Text] [Related]
18. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
Mauri C; Feldmann M; Williams RO
Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
[TBL] [Abstract][Full Text] [Related]
20. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.
Cooper SM; Sriram S; Ranges GE
J Immunol; 1988 Sep; 141(6):1958-62. PubMed ID: 3139747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
